scispace - formally typeset
M

Marie-Caroline Dieu-Nosjean

Researcher at University of Paris

Publications -  82
Citations -  12410

Marie-Caroline Dieu-Nosjean is an academic researcher from University of Paris. The author has contributed to research in topics: Immune system & Tumor microenvironment. The author has an hindex of 46, co-authored 75 publications receiving 10320 citations. Previous affiliations of Marie-Caroline Dieu-Nosjean include Schering-Plough & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Immune infiltration in human tumors: a prognostic factor that should not be ignored.

TL;DR: An immune scoring based on the type, density and location of lymphocyte infiltrates as a novel prognostic factor for use in addition to tumor node metastasis staging to predict disease-free survival and to aid in decisions regarding adjuvant therapies in early stage human cancers.
Journal ArticleDOI

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

TL;DR: Univariate analysis showed that the density of mature DCs was highly associated with a favorable clinical outcome (overall, disease-specific, and disease-free survival), suggesting that Ti-BALT may participate in antitumoral immunity.
Journal ArticleDOI

Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors

TL;DR: By combining immunostaining and real-time imaging in viable slices of human lung tumors, it is revealed that the density and the orientation of the stromal extracellular matrix likely play key roles in controlling the migration of T cells.
Journal ArticleDOI

Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis

TL;DR: C cultured primary keratinocytes, dermal fibroblasts, and dermal microvascular endothelial and dendritic cells are major sources of CCL20, and that the expression of this chemokine can be induced by proinflammatory mediators such as TNF-α/IL-1β, CD40 ligand, IFN-γ, or IL-17 are shown.